Home / MBXBF : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does MBXBF make money? Does MBXBF have pricing power? What's the Earnings Whisper? Will MBXBF profit more as the business scales? What is MBXBF's management track record? Is MBXBF's current price justified?

Microbix Biosystems Inc.

$0.22 +$0.04 (+23.51%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

$0.21

Day Range

$0.22 - $0.22

Year Range

$0.15$0.23

Market Cap

29.84M

AVG Volume

8.64K

Trailing/Forward PE

-8.78/21.53

PEG ratio

0.04

Dividend Yield

Next Earnings Date

2026-12-17

Primary Exchange

Other OTC

Revenue (CAD)

MBXBF Revenue (CAD) by year
Period	Revenue (CAD)
2025	18.59M
2024	25.39M
2023	16.51M
2022	19.08M
2021	18.59M
2020	10.52M
2019	13.41M
2018	12.51M
2017	10.19M
2016	9.52M

Net Income (CAD)

MBXBF Net Income (CAD) by year
Period	Net Income (CAD)
2025	-1.77M
2024	3.52M
2023	-435.81K
2022	1.39M
2021	3.23M
2020	-6.23M
2019	31.92K
2018	-8.62M
2017	-3.78M
2016	748.41K

Operating Income (CAD)

MBXBF Operating Income (CAD) by year
Period	Operating Income (CAD)
2025	-1.71M
2024	3.91M
2023	799.9K
2022	2.69M
2021	4.84M
2020	-4.41M
2019	43.68K
2018	-742.81K
2017	-1.5M
2016	148.41K

EBITDA (CAD)

MBXBF EBITDA (CAD) by year
Period	EBITDA (CAD)
2025	250.09K
2024	6.09M
2023	-1.44M
2022	3.73M
2021	5.66M
2020	-2.91M
2019	1.54M
2018	-7.08M
2017	-3M
2016	1.25M

Cash Flows (CAD)

MBXBF Cash Flows (CAD) by year
Period	Cash Flows (CAD)
2025	-877.68K
2024	2.44M
2023	-2.11M
2022	1.44M
2021	804.2K
2020	-805.34K
2019	-470.43K
2018	-1.76M
2017	-358.45K
2016	-727.82K

EPS (CAD)

MBXBF EPS (CAD) by year
Period	EPS (CAD)
2025	-0.02
2024	0.03
2023	-0
2022	0.01
2021	0.02
2020	-0.06
2019	0
2018	-0.07
2017	-0.04
2016	0.01

Expenses (CAD)

MBXBF Expenses (CAD) by year
Period	Expenses (CAD)
2025	12.24M
2024	12.91M
2023	11.07M
2022	10.38M
2021	7.41M
2020	5.98M
2019	5.95M
2018	6.48M
2017	6.04M
2016	5.78M

Cash & Debt (CAD)

MBXBF Cash & Debt (CAD) by year
Period	Cash & Debt (CAD)
2025	12.13M
2024	12.96M
2023	11.61M
2022	13.49M
2021	9.99M
2020	92.66K
2019	95.57K
2018	44.36K
2017	54.46K
2016	5.42K

Debt ratios

MBXBF Debt ratios by year
Period	Debt ratios
2025	-0.62
2024	-0.47
2023	-0.99
2022	-0.96
2021	0.81
2020	-0.53
2019	-0.95
2018	-0.85

Margins

MBXBF Margins by year
Period	Margins
2025	53%
2024	60.61%
2023	45.3%
2022	58.32%
2021	59.4%
2020	44.28%
2019	48.82%
2018	42.92%
2017	47.25%
2016	52.33%

Return on Capital

MBXBF Return on Capital by year
Period	Return on Capital
2025	-6.34%
2024	12.44%
2023	-1.77%
2022	5.58%
2021	17.42%
2020	-94.08%
2019	0.3%
2018	-83.27%
2017	-24.91%
2016	4.89%

Shares Outstanding

MBXBF Shares Outstanding by year
Period	Shares Outstanding
2025	139.25M
2024	135.81M
2023	136.85M
2022	138.99M
2021	129.82M
2020	108.77M
2019	96.97M
2018	122.85M
2017	86.99M
2016	87.91M

Book Value Per Share (CAD)

MBXBF Book Value Per Share (CAD) by year
Period	Book Value Per Share (CAD)
2025	0.2
2024	0.21
2023	0.18
2022	0.18
2021	0.14
2020	0.06
2019	0.11
2018	0.08
2017	0.17
2016	0.17

Total Assets (CAD)

MBXBF Total Assets (CAD) by year
Period	Total Assets (CAD)
2025	37.46M
2024	38.1M
2023	35.65M
2022	33.15M
2021	28.83M
2020	15.6M
2019	19.63M
2018	19.31M
2017	26.44M
2016	25.25M

PE Ratio

MBXBF PE Ratio by year
Period	PE Ratio
Sep 25	24.04
Sep 25	21.66
Sep 25	20.63
Sep 25	20.39
Aug 25	21.16
Aug 25	20.75
Aug 25	22.22
Aug 25	25.81
Aug 25	26.37
Jul 25	26.2
Jul 25	26.85
Jul 25	26.42
Jul 25	26.58
Jun 25	20.99
Jun 25	21.5
Jun 25	21.56
Jun 25	23.06
May 25	23.14
May 25	24.34
May 25	24.51
May 25	24.94
May 25	26.18
Apr 25	23.82
Apr 25	25.67
Apr 25	24.82
Apr 25	29.86
Mar 25	16.24
Mar 25	15.5
Mar 25	15.35
Mar 25	14.79
Feb 25	16.97
Feb 25	19.01
Feb 25	20.79
Feb 25	18.9
Jan 25	18.71
Jan 25	18.85
Jan 25	16.87
Jan 25	16.56
Jan 25	16.16
Dec 24	10.91
Dec 24	10.65
Dec 24	9.2
Dec 24	9.38
Nov 24	8.38
Nov 24	8.1
Nov 24	8.31
Nov 24	8.58
Nov 24	8.34
Oct 24	9.09
Oct 24	9.15
Oct 24	9.33
Oct 24	9.88
Sep 24	11.56
Sep 24	11.61
Sep 24	11.9
Sep 24	13.08
Aug 24	12.95
Aug 24	12.24
Aug 24	11.7
Aug 24	10.03
Aug 24	10.13
Jul 24	10.11
Jul 24	10.91
Jul 24	10.27
Jul 24	10.15
Jun 24	11.82
Jun 24	15.04
Jun 24	12.92
Jun 24	13.29
May 24	12.88
May 24	12.6
May 24	13.51
Apr 24	13.02
Apr 24	13.86
Apr 24	14.53
Apr 24	14.67
Mar 23	36.78
Mar 23	36.37
Mar 23	33.97
Mar 23	33.69
Feb 23	38.47
Feb 23	39.57
Feb 23	30.2
Feb 23	37.35
Jan 23	38.28
Jan 23	38.75
Jan 23	38.88
Jan 23	39.62
Dec 22	39.99
Dec 22	20.99
Dec 22	22.31
Dec 22	23.08
Dec 22	22.78
Nov 22	24.36
Nov 22	25.08
Nov 22	25.33
Nov 22	25.96
Oct 22	25.35
Oct 22	25.71
Oct 22	24.78

Free Cash Flow Yield

MBXBF Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-13.16%
Sep 26	-13.19%
Aug 26	-13.13%
Aug 26	-13.26%
Aug 26	-12.98%
Aug 26	-12.92%
Jul 26	-12.85%
Jul 26	-12.83%
Jul 26	-13.39%
Jul 26	-13.02%
Jul 26	-12.93%
Jun 26	-10.23%
Jun 26	-9.84%
Jun 26	-11.65%
Jun 26	-11.69%
May 26	-11.66%
May 26	-12.14%
May 26	-13.44%
May 26	-12.52%
May 26	-12.33%
Apr 26	-12.74%
Apr 26	-13.25%
Apr 26	-13.11%
Apr 26	-13.43%
Mar 26	-2.64%
Mar 26	-2.53%
Mar 26	-2.44%
Mar 26	-2.72%
Feb 26	-2.68%
Feb 26	-2.92%
Feb 26	-2.93%
Feb 26	-2.92%
Jan 26	-2.92%
Jan 26	-2.72%
Jan 26	-2.5%
Jan 26	-2.52%
Jan 26	-2.61%
Dec 25	-0.86%
Dec 25	-0.88%
Dec 25	-0.78%
Dec 25	-0.85%
Nov 25	-0.78%
Nov 25	-0.8%
Nov 25	-0.76%
Nov 25	-0.77%
Oct 25	-0.76%
Oct 25	-0.78%
Oct 25	-0.74%
Oct 25	-0.7%
Oct 25	-0.75%
Sep 25	5.98%
Sep 25	6.63%
Sep 25	6.97%
Sep 25	7.05%
Aug 25	6.79%
Aug 25	6.92%
Aug 25	6.47%
Aug 25	5.57%
Aug 25	5.45%
Jul 25	5.49%
Jul 25	5.35%
Jul 25	5.44%
Jul 25	5.41%
Jun 25	4.28%
Jun 25	4.18%
Jun 25	4.17%
Jun 25	3.9%
May 25	3.89%
May 25	3.69%
May 25	3.67%
May 25	3.61%
May 25	3.44%
Apr 25	3.78%
Apr 25	3.5%
Apr 25	3.62%
Apr 25	3.01%
Mar 25	4.27%
Mar 25	4.47%
Mar 25	4.52%
Mar 25	4.69%
Feb 25	4.09%
Feb 25	3.65%
Feb 25	3.34%
Feb 25	3.67%
Jan 25	3.71%
Jan 25	3.68%
Jan 25	4.11%
Jan 25	4.19%
Jan 25	4.29%
Dec 24	0.6%
Dec 24	0.61%
Dec 24	0.71%
Dec 24	0.69%
Nov 24	0.78%
Nov 24	0.8%
Nov 24	0.78%
Nov 24	0.76%
Nov 24	0.78%
Oct 24	0.72%
Oct 24	0.71%

Price to Sales

MBXBF Price to Sales by year
Period	Price to Sales
Sep 26	2.82
Sep 26	2.81
Aug 26	2.82
Aug 26	2.79
Aug 26	2.85
Aug 26	2.87
Jul 26	2.88
Jul 26	2.89
Jul 26	2.77
Jul 26	2.85
Jul 26	2.87
Jun 26	2.47
Jun 26	2.57
Jun 26	2.17
Jun 26	2.16
May 26	2.17
May 26	2.08
May 26	1.88
May 26	2.02
May 26	2.05
Apr 26	1.98
Apr 26	1.91
Apr 26	1.93
Apr 26	1.88
Mar 26	1.79
Mar 26	1.86
Mar 26	1.94
Mar 26	1.74
Feb 26	1.76
Feb 26	1.62
Feb 26	1.61
Feb 26	1.62
Jan 26	1.62
Jan 26	1.73
Jan 26	1.89
Jan 26	1.88
Jan 26	1.81
Dec 25	1.49
Dec 25	1.46
Dec 25	1.65
Dec 25	1.52
Nov 25	1.64
Nov 25	1.6
Nov 25	1.69
Nov 25	1.66
Oct 25	1.68
Oct 25	1.65
Oct 25	1.73
Oct 25	1.84
Oct 25	1.71
Sep 25	1.66
Sep 25	1.49
Sep 25	1.42
Sep 25	1.4
Aug 25	1.46
Aug 25	1.43
Aug 25	1.53
Aug 25	1.78
Aug 25	1.82
Jul 25	1.8
Jul 25	1.85
Jul 25	1.82
Jul 25	1.83
Jun 25	1.75
Jun 25	1.79
Jun 25	1.8
Jun 25	1.92
May 25	1.93
May 25	2.03
May 25	2.05
May 25	2.08
May 25	2.18
Apr 25	1.99
Apr 25	2.14
Apr 25	2.07
Apr 25	2.49
Mar 25	2.25
Mar 25	2.15
Mar 25	2.13
Mar 25	2.05
Feb 25	2.35
Feb 25	2.63
Feb 25	2.88
Feb 25	2.62
Jan 25	2.59
Jan 25	2.61
Jan 25	2.34
Jan 25	2.3
Jan 25	2.24
Dec 24	2.37
Dec 24	2.31
Dec 24	2
Dec 24	2.04
Nov 24	1.82
Nov 24	1.76
Nov 24	1.81
Nov 24	1.86
Nov 24	1.81
Oct 24	1.97
Oct 24	1.99

EV/EBITDA

MBXBF EV/EBITDA by year
Period	EV/EBITDA
Mar 26	111.65
Mar 26	117.18
Mar 26	122.53
Mar 26	107.72
Feb 26	109.39
Feb 26	98.91
Feb 26	98.39
Feb 26	98.88
Jan 26	98.68
Jan 26	107.43
Jan 26	118.84
Jan 26	118.03
Jan 26	112.92
Dec 25	10.46
Dec 25	10.18
Dec 25	11.8
Dec 25	10.67
Nov 25	11.69
Nov 25	11.42
Nov 25	12.17
Nov 25	11.87
Oct 25	12.04
Oct 25	11.79
Oct 25	12.54
Oct 25	13.42
Oct 25	12.34
Sep 25	6.54
Sep 25	5.68
Sep 25	5.31
Sep 25	5.22
Aug 25	5.5
Aug 25	5.36
Aug 25	5.89
Aug 25	7.18
Aug 25	7.38
Jul 25	7.32
Jul 25	7.55
Jul 25	7.4
Jul 25	7.46
Jun 25	7.24
Jun 25	7.45
Jun 25	7.47
Jun 25	8.09
May 25	8.12
May 25	8.62
May 25	8.69
May 25	8.86
May 25	9.38
Apr 25	8.4
Apr 25	9.17
Apr 25	8.81
Apr 25	10.89
Mar 25	8.31
Mar 25	7.88
Mar 25	7.8
Mar 25	7.47
Feb 25	8.73
Feb 25	9.91
Feb 25	10.94
Feb 25	9.84
Jan 25	9.74
Jan 25	9.82
Jan 25	8.67
Jan 25	8.49
Jan 25	8.26
Dec 24	12.22
Dec 24	11.89
Dec 24	10.05
Dec 24	10.28
Nov 24	9
Nov 24	8.65
Nov 24	8.92
Nov 24	9.26
Nov 24	8.96
Oct 24	9.91
Oct 24	9.98
Oct 24	10.21
Oct 24	10.91
Sep 24	14.29
Sep 24	14.36
Sep 24	14.77
Sep 24	16.45
Aug 24	16.27
Aug 24	15.26
Aug 24	14.49
Aug 24	12.11
Aug 24	12.26
Jul 24	12.22
Jul 24	13.37
Jul 24	12.46
Jul 24	12.28
Jun 24	14.92
Jun 24	19.67
Jun 24	16.54
Jun 24	17.09
May 24	16.48
May 24	16.06
May 24	17.41
Apr 24	16.68
Apr 24	17.93

Price/Operating Cashflow

MBXBF Price/Operating Cashflow by year
Period	Price/Operating Cashflow
Dec 25	52.38
Dec 25	51.25
Dec 25	57.91
Dec 25	53.26
Nov 25	57.45
Nov 25	56.32
Nov 25	59.41
Nov 25	58.17
Oct 25	58.88
Oct 25	57.87
Oct 25	60.91
Oct 25	64.55
Oct 25	60.11
Sep 25	9.57
Sep 25	8.63
Sep 25	8.21
Sep 25	8.12
Aug 25	8.43
Aug 25	8.26
Aug 25	8.85
Aug 25	10.28
Aug 25	10.5
Jul 25	10.43
Jul 25	10.69
Jul 25	10.52
Jul 25	10.59
Jun 25	10.61
Jun 25	10.87
Jun 25	10.9
Jun 25	11.66
May 25	11.7
May 25	12.31
May 25	12.39
May 25	12.61
May 25	13.24
Apr 25	12.04
Apr 25	12.98
Apr 25	12.55
Apr 25	15.1
Mar 25	13.15
Mar 25	12.55
Mar 25	12.43
Mar 25	11.97
Feb 25	13.74
Feb 25	15.39
Feb 25	16.83
Feb 25	15.3
Jan 25	15.15
Jan 25	15.26
Jan 25	13.66
Jan 25	13.41
Jan 25	13.08
Dec 24	26.07
Dec 24	25.44
Dec 24	21.98
Dec 24	22.41
Nov 24	20.01
Nov 24	19.34
Nov 24	19.86
Nov 24	20.5
Nov 24	19.93
Oct 24	21.71
Oct 24	21.85
Oct 24	22.28
Oct 24	23.59
Sep 24	16.46
Sep 24	16.52
Sep 24	16.94
Sep 24	18.62
Aug 24	18.44
Aug 24	17.42
Aug 24	16.66
Aug 24	14.27
Aug 24	14.42
Jul 24	14.39
Jul 24	15.53
Jul 24	14.62
Jul 24	14.44
Jun 24	43.35
Jun 24	55.13
Jun 24	47.37
Jun 24	48.74
May 24	47.24
May 24	46.19
May 24	49.54
Apr 24	47.73
Apr 24	50.81
Apr 24	53.26
Apr 24	53.79
Dec 23	98.06
Dec 23	101.39
Dec 23	91.89
Dec 23	74.5
Nov 23	73.77
Nov 23	83.01
Nov 23	63.96
Nov 23	70.23
Oct 23	77.73
Oct 23	80.42
Oct 23	79.1

Price to Book

MBXBF Price to Book by year
Period	Price to Book
Sep 26	1.66
Sep 26	1.65
Aug 26	1.66
Aug 26	1.64
Aug 26	1.68
Aug 26	1.69
Jul 26	1.7
Jul 26	1.7
Jul 26	1.63
Jul 26	1.67
Jul 26	1.69
Jun 26	1.56
Jun 26	1.62
Jun 26	1.37
Jun 26	1.36
May 26	1.37
May 26	1.31
May 26	1.19
May 26	1.27
May 26	1.29
Apr 26	1.25
Apr 26	1.2
Apr 26	1.22
Apr 26	1.19
Mar 26	1.2
Mar 26	1.25
Mar 26	1.29
Mar 26	1.16
Feb 26	1.18
Feb 26	1.08
Feb 26	1.08
Feb 26	1.08
Jan 26	1.08
Jan 26	1.16
Jan 26	1.26
Jan 26	1.25
Jan 26	1.21
Dec 25	1.08
Dec 25	1.05
Dec 25	1.19
Dec 25	1.09
Nov 25	1.18
Nov 25	1.16
Nov 25	1.22
Nov 25	1.19
Oct 25	1.21
Oct 25	1.19
Oct 25	1.25
Oct 25	1.32
Oct 25	1.23
Sep 25	1.21
Sep 25	1.09
Sep 25	1.04
Sep 25	1.03
Aug 25	1.07
Aug 25	1.05
Aug 25	1.12
Aug 25	1.3
Aug 25	1.33
Jul 25	1.32
Jul 25	1.35
Jul 25	1.33
Jul 25	1.34
Jun 25	1.4
Jun 25	1.43
Jun 25	1.43
Jun 25	1.53
May 25	1.54
May 25	1.62
May 25	1.63
May 25	1.66
May 25	1.74
Apr 25	1.58
Apr 25	1.71
Apr 25	1.65
Apr 25	1.99
Mar 25	2.02
Mar 25	1.93
Mar 25	1.91
Mar 25	1.84
Feb 25	2.11
Feb 25	2.36
Feb 25	2.59
Feb 25	2.35
Jan 25	2.33
Jan 25	2.35
Jan 25	2.1
Jan 25	2.06
Jan 25	2.01
Dec 24	1.98
Dec 24	1.93
Dec 24	1.67
Dec 24	1.7
Nov 24	1.52
Nov 24	1.47
Nov 24	1.51
Nov 24	1.55
Nov 24	1.51
Oct 24	1.65
Oct 24	1.66

No video analysis for this stock yet. Request one from our team.

News: MBXBF

accessnewswire.com · 9 Sep 2026

Microbix Qualifies as Supplier for Five Major Dx Test-Makers Product Lines for Support of Leading IVD Manufacturers

MISSISSAUGA, ON / ACCESS Newswire / September 9, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF)(Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it has completed formal qualification to become a supplier for five in-vitro diagnostics (IVD) manufacturers ("Dx Test-Makers"). Each of these five Dx Test-Makers are considered to be one of the ten largest such companies by revenues, and Microbix is pleased to have successfully completed their supplier audit & quality review processes.

seekingalpha.com · 13 Aug 2026

Microbix Biosystems Inc. (MBX:CA) Q3 2026 Earnings Call Transcript

accessnewswire.com · 13 Aug 2026

Microbix Reports Results for Q3 Fiscal 2026

Q3 Revenues of $4.1 million and Controlled Net Loss MISSISSAUGA, ON / ACCESS Newswire / August 13, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, reports results for its third quarter and nine months of fiscal 2026 ended June 30, 2026 ("Q3" and "YTD"). Results for Q3 and YTD continue to demonstrate the results of the Company's continuing work to rebuild revenues back to profitability following two client setbacks in mid-2025, with revenue growth of 17% in Q3 compared to Q3 fiscal 2025.

accessnewswire.com · 6 Aug 2026

Microbix Schedules Release of Results for Q3 Fiscal 2026

Results Release and Webinar Discussion on Morning of August 13, 2026 MISSISSAUGA, ON / ACCESS Newswire / August 6, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF), (Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it expects to file the financial statements, management disclosure and analysis, and results news release for its third quarter of fiscal 2026 ended June 30, 2026 ("Q3 2026") prior to the start of trading on August 13, 2026. At 10:00 AM ET that day, Microbix intends to hold a webinar discussion of Q3 2026 results with its CEO, CFO, and COO.